Recent News
On April 28, 2026 Centene reported first-quarter 2026 results, citing stronger-than-expected adjusted EPS and updated commentary on 2026 guidance; earlier on April 6, 2026 the company announced a new executive leadership structure reporting to the CEO; investor materials and press releases in mid‑May and April referenced upcoming investor events and community initiatives tied to affordable housing and local partnerships.
Technical Analysis
ADX stands at 53.7, indicating a very strong trend environment that magnifies directional moves but does not specify direction; this strength raises the odds that any breakout or breakdown carries follow‑through and therefore amplifies near‑term price bias relative to the stated valuation.
Directional indicators present a mixed directional signal: DI+ at 37.51 shows a peak-and-reversal pattern, which reads as a bearish change in bullish pressure, while DI− at 10.81 also shows a peak-and-reversal pattern, which reads as a bullish change in bearish pressure. The opposing DI signals produce short-term ambiguity; with ADX elevated, that ambiguity favors whichever side gains momentum first.
MACD sits at 3.69 with the signal line at 3.66 and a documented dip-and-reversal trend; the MACD has crossed above its signal line, which constitutes a bullish momentum signal and supports the possibility of continued upside extension from current levels.
Price sits near the upper Bollinger band (upper ~$64.3–$67.57) at a close of $65.34, above the 20‑day average ($61.04), the 50‑day average ($50.46) and the 200‑day average ($41.04); the 12‑day EMA shows an increasing trend. Those placements create clear technical support in the low $60s and place recent trading near resistance—momentum favors higher levels but leaves limited immediate room before short-term mean reversion risks increase.
MRO reads 5.51 (positive), implying price currently sits above the implied target and carries some pressure toward a decrease; combined with RSI at 68.87 and an RSI peak-and-reversal pattern (bearish), technical momentum indicates a material risk of a short-lived pullback even as MACD momentum supports continuation—net technical posture: bullish bias with vulnerability to a near-term retracement.
Fundamental Analysis
Profitability and earnings: EBIT equals $2,263,000,000 and EBITDA equals $2,563,000,000, producing an EBIT margin of 4.53%. EBIT margin changed QoQ by −263.87% and improved YoY by 10.24%. Adjusted EPS reported $3.37 versus an estimate of $2.13, a beat of $1.24 or a 58.22% surprise, and management reiterated improved profitability drivers tied to medical-cost management and PDP growth in recent commentary.
Cash flow and valuation metrics: Operating cash flow reached $4,366,000,000 and free cash flow totaled $4,166,000,000, producing a free-cash-flow yield of 21.95%, substantially above the industry peer mean of 2.88% for this metric. WMDST values the stock as under-valued, consistent with an enterprise multiple of 4.53 and a market cap of $18,978,550,016 versus enterprise value of $11,608,550,016.
Capital structure and coverage: Total debt stands at $16,371,000,000 with debt/EBITDA about 6.39x and interest coverage roughly 13.80x, indicating the company retains ample ability to service interest despite leverage measured on an EBITDA basis; debt-to-equity sits near 0.76 and debt-to-assets near 0.20.
Growth and efficiency: Reported revenue equals $49,944,000,000 with gross profit $5,558,000,000 and gross margin 11.13%. Revenue growth quarter-over-quarter measured 5.29% while year‑over‑year revenue growth shows a reported value of −96.91%; asset turnover sits at 0.63, modestly above the industry peer mean of 0.52. Return on equity equals 7.19% and return on invested capital equals 4.39%, both positive and showing YoY improvements noted in the dataset.
Valuation comparisons: Price/earnings sits at 11.45 and price/book at 0.89—both below the industry peer mean values provided—while forward PE runs near 38.69 reflecting lower forward EPS consensus; the large gap between current P/E and forward P/E reflects differing near-term EPS expectations embedded in markets versus reported results. Free cash flow yield materially exceeds the industry peer mean, supporting WMDST’s undervaluation determination.
MOST-RECENT QUARTERLY REPORT
| REPORT PERIOD ENDING: | 2026-03-31 |
| REPORT DATE: | 2026-04-28 |
| NEXT REPORT DATE: | 2026-07-28 |
| CASH FLOW | Begin Period Cash Flow | $ 18.0 B |
| Operating Cash Flow | $ 4.4 B | |
| Capital Expenditures | $ -200.00 M | |
| Change In Working Capital | $ 2.5 B | |
| Dividends Paid | — | |
| Cash Flow Delta | $ 3.4 B | |
| End Period Cash Flow | $ 21.4 B | |
| INCOME STATEMENT | REVENUE | |
| Total Revenue | $ 49.9 B | |
| Forward Revenue | $ 4.5 B | |
| COSTS | ||
| Cost Of Revenue | $ 44.4 B | |
| Depreciation | $ 134.0 M | |
| Depreciation and Amortization | $ 300.0 M | |
| Research and Development | — | |
| Total Operating Expenses | $ 48.1 B | |
| PROFITABILITY | ||
| Gross Profit | $ 5.6 B | |
| EBITDA | $ 2.6 B | |
| EBIT | $ 2.3 B | |
| Operating Income | $ 1.9 B | |
| Interest Income | — | |
| Interest Expense | $ 164.0 M | |
| Net Interest Income | $ -164.00 M | |
| Income Before Tax | $ 2.1 B | |
| Tax Provision | $ 560.0 M | |
| Tax Rate | 26.7 % | |
| Net Income | $ 1.5 B | |
| Net Income From Continuing Operations | $ 1.5 B | |
| EARNINGS | ||
| EPS Estimate | $ 2.13 | |
| EPS Actual | $ 3.37 | |
| EPS Difference | $ 1.24 | |
| EPS Surprise | 58.216 % | |
| Forward EPS | $ 1.11 | |
| BALANCE SHEET | ASSETS | |
| Total Assets | $ 81.2 B | |
| Intangible Assets | $ 15.2 B | |
| Net Tangible Assets | $ 6.2 B | |
| Total Current Assets | $ 45.0 B | |
| Cash and Short-Term Investments | $ 23.7 B | |
| Cash | $ 21.3 B | |
| Net Receivables | $ 19.4 B | |
| Inventory | — | |
| Long-Term Investments | $ 2.3 B | |
| LIABILITIES | ||
| Accounts Payable | $ 16.8 B | |
| Short-Term Debt | $ 63.0 M | |
| Total Current Liabilities | $ 40.0 B | |
| Net Debt | — | |
| Total Debt | $ 16.4 B | |
| Total Liabilities | $ 59.6 B | |
| EQUITY | ||
| Total Equity | $ 21.4 B | |
| Retained Earnings | $ 10.2 B | |
| VALUATION & PER-SHARE METRICS | EQUITY & PER-SHARE METRICS | |
| Book Value Per-Share | $ 43.57 | |
| Shares Outstanding | 493.771 M | |
| Revenue Per-Share | $ 101.56 | |
| VALUATION | Market Capitalization | $ 19.0 B |
| Enterprise Value | $ 11.6 B | |
| Enterprise Multiple | 4.529 | |
| Enterprise Multiple QoQ | -126.166 % | |
| Enterprise Multiple YoY | -67.7 % | |
| Enterprise Multiple IPRWA | high: 159.017 median: 41.816 mean: 36.158 CNC: 4.529 low: -42.479 |
|
| EV/R | 0.232 | |
| CAPITAL STRUCTURE | ||
| Asset To Equity | 3.788 | |
| Asset To Liability | 1.361 | |
| Debt To Capital | 0.433 | |
| Debt To Assets | 0.202 | |
| Debt To Assets QoQ | -14.777 % | |
| Debt To Assets YoY | -4.176 % | |
| Debt To Assets IPRWA | high: 0.935 mean: 0.36 median: 0.262 CNC: 0.202 low: 0.006 |
|
| Debt To Equity | 0.764 | |
| Debt To Equity QoQ | -16.062 % | |
| Debt To Equity YoY | 16.425 % | |
| Debt To Equity IPRWA | high: 6.239 CNC: 0.764 median: 0.732 mean: -0.104 low: -6.439 |
|
| PRICE-BASED VALUATION | ||
| Price To Book (P/B) | 0.886 | |
| Price To Book QoQ | -12.786 % | |
| Price To Book YoY | -18.264 % | |
| Price To Book IPRWA | high: 13.088 mean: 2.183 median: 1.563 CNC: 0.886 low: -0.307 |
|
| Price To Earnings (P/E) | 11.452 | |
| Price To Earnings QoQ | -133.072 % | |
| Price To Earnings YoY | -45.381 % | |
| Price To Earnings IPRWA | high: 167.375 mean: 49.421 median: 38.698 CNC: 11.452 low: -165.821 |
|
| PE/G Ratio | -0.03 | |
| Price To Sales (P/S) | 0.38 | |
| Price To Sales QoQ | -6.753 % | |
| Price To Sales YoY | -41.438 % | |
| Price To Sales IPRWA | high: 11.743 mean: 2.655 median: 1.073 CNC: 0.38 low: 0.026 |
|
| FORWARD MULTIPLES | ||
| Forward P/E | 38.694 | |
| Forward PE/G | -0.101 | |
| Forward P/S | 4.737 | |
| EFFICIENCY | OPERATIONAL | |
| Operating Leverage | -600.746 | |
| ASSET & SALES | ||
| Asset Turnover Ratio | 0.633 | |
| Asset Turnover Ratio QoQ | 1.019 % | |
| Asset Turnover Ratio YoY | 14.977 % | |
| Asset Turnover Ratio IPRWA | high: 1.21 CNC: 0.633 mean: 0.518 median: 0.397 low: 0.013 |
|
| Receivables Turnover | 2.661 | |
| Receivables Turnover Ratio QoQ | 10.297 % | |
| Receivables Turnover Ratio YoY | 20.312 % | |
| Receivables Turnover Ratio IPRWA | high: 9.342 median: 3.671 mean: 3.556 CNC: 2.661 low: 0.052 |
|
| Inventory Turnover | — | |
| Inventory Turnover Ratio QoQ | — | |
| Inventory Turnover Ratio YoY | — | |
| Inventory Turnover Ratio IPRWA | — | |
| Days Sales Outstanding (DSO) | 34.285 | |
| CASH CYCLE | ||
| Cash Conversion Cycle Days (CCC) | 4.878 | |
| Cash Conversion Cycle Days QoQ | — | |
| Cash Conversion Cycle Days YoY | — | |
| Cash Conversion Cycle Days IPRWA | high: 101.8 median: 19.637 mean: 16.515 CNC: 4.878 low: -62.922 |
|
| CAPITAL DEPLOYMENT | ||
| Cash Conversion Ratio | 10.102 | |
| CapEx To Revenue | -0.004 | |
| CapEx To Depreciation | -1.493 | |
| CAPITAL, LIQUIDITY & COVERAGE | CAPITAL STRUCTURE | |
| Total Capital | $ 37.7 B | |
| Net Invested Capital | $ 37.8 B | |
| Invested Capital | $ 37.8 B | |
| Net Tangible Assets | $ 6.2 B | |
| Net Working Capital | $ 4.9 B | |
| LIQUIDITY | ||
| Cash Ratio | 0.593 | |
| Current Ratio | 1.123 | |
| Current Ratio QoQ | 2.122 % | |
| Current Ratio YoY | 1.067 % | |
| Current Ratio IPRWA | high: 3.361 CNC: 1.123 mean: 0.991 median: 0.854 low: 0.273 |
|
| Quick Ratio | — | |
| Quick Ratio QoQ | — | |
| Quick Ratio YoY | — | |
| Quick Ratio IPRWA | — | |
| COVERAGE & LEVERAGE | ||
| Debt To EBITDA | 6.387 | |
| Cost Of Debt | 0.696 % | |
| Interest Coverage Ratio | 13.799 | |
| Interest Coverage Ratio QoQ | -268.596 % | |
| Interest Coverage Ratio YoY | 22.432 % | |
| Interest Coverage Ratio IPRWA | high: 35.836 CNC: 13.799 mean: 11.729 median: 7.359 low: -1.125 |
|
| Operating Cash Flow Ratio | 0.093 | |
| TIMING / LIQUIDITY | ||
| Days Payables Outstanding (DPO) | 29.407 | |
| DIVIDENDS | ||
| Dividend Coverage Ratio | — | |
| Dividend Payout Ratio | — | |
| Dividend Rate | — | |
| Dividend Yield | — | |
| PERFORMANCE | GROWTH | |
| Asset Growth Rate | 5.77 % | |
| Revenue Growth | 0.44 % | |
| Revenue Growth QoQ | 528.571 % | |
| Revenue Growth YoY | -96.912 % | |
| Revenue Growth IPRWA | high: 21.958 % CNC: 0.44 % mean: -2.21 % median: -4.983 % low: -9.495 % |
|
| Earnings Growth | -383.193 % | |
| Earnings Growth QoQ | 13.371 % | |
| Earnings Growth YoY | -245.978 % | |
| Earnings Growth IPRWA | high: 157.143 % mean: 25.003 % median: 1.648 % low: -200.0 % CNC: -383.193 % |
|
| MARGINS | ||
| Gross Margin | 11.128 % | |
| Gross Margin QoQ | 124.31 % | |
| Gross Margin YoY | -0.269 % | |
| Gross Margin IPRWA | high: 96.442 % mean: 25.743 % median: 15.558 % CNC: 11.128 % low: 4.2 % |
|
| EBIT Margin | 4.531 % | |
| EBIT Margin QoQ | -263.87 % | |
| EBIT Margin YoY | 10.243 % | |
| EBIT Margin IPRWA | high: 23.127 % mean: 7.315 % median: 4.692 % CNC: 4.531 % low: -12.88 % |
|
| Return On Sales (ROS) | 3.726 % | |
| Return On Sales QoQ | -250.363 % | |
| Return On Sales YoY | -9.343 % | |
| Return On Sales IPRWA | high: 22.401 % mean: 7.483 % median: 4.66 % CNC: 3.726 % low: -12.88 % |
|
| CASH FLOW | ||
| Free Cash Flow (FCF) | $ 4.2 B | |
| Free Cash Flow Yield | 21.951 % | |
| Free Cash Flow Yield QoQ | 1886.516 % | |
| Free Cash Flow Yield YoY | 382.97 % | |
| Free Cash Flow Yield IPRWA | CNC: 21.951 % high: 13.5 % median: 3.132 % mean: 2.88 % low: -7.715 % |
|
| Free Cash Growth | 1759.821 % | |
| Free Cash Growth QoQ | -2287.825 % | |
| Free Cash Growth YoY | -716.27 % | |
| Free Cash Growth IPRWA | CNC: 1759.821 % high: 298.093 % mean: 17.28 % median: 2.874 % low: -455.219 % |
|
| Free Cash To Net Income | 2.703 | |
| Cash Flow Margin | 7.456 % | |
| Cash Flow To Earnings | 2.417 | |
| VALUE & RETURNS | ||
| Economic Value Added | $ 0.03 | |
| Return On Assets (ROA) | 1.952 % | |
| Return On Assets QoQ | -240.837 % | |
| Return On Assets YoY | 26.18 % | |
| Return On Assets IPRWA | high: 4.991 % CNC: 1.952 % median: 1.8 % mean: 1.712 % low: -5.482 % |
|
| Return On Capital Employed (ROCE) | 5.502 % | |
| Return On Equity (ROE) | 0.072 | |
| Return On Equity QoQ | -230.337 % | |
| Return On Equity YoY | 53.152 % | |
| Return On Equity IPRWA | high: 0.27 CNC: 0.072 median: 0.038 mean: -0.029 low: -0.261 |
|
| DuPont ROE | 7.447 % | |
| Return On Invested Capital (ROIC) | 4.39 % | |
| Return On Invested Capital QoQ | -267.302 % | |
| Return On Invested Capital YoY | 40.705 % | |
| Return On Invested Capital IPRWA | high: 7.871 % CNC: 4.39 % mean: 3.545 % median: 2.946 % low: -6.018 % |
|